Skip to content
AnalystLens
Back to MRNAPer Share

Moderna, Inc. Weighted Avg Shares (Diluted) 2019-2026 | MRNA

Annual FY2019–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

389.0M

+1.3%YoY vs FY2024Source: 10-KFY2025

From 331.0M in FY2019 to 389.0M in FY2025: 1.2× in 6 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26395M+2.3%Not reportedNot reportedNot reported
FY25386M+1.0%388M+1.0%390M−2.3%Not reported
FY24382M−5.7%384M+0.8%399M+4.7%Not reported
FY23405M−4.9%381M−9.1%381M−7.5%Not reported
FY22426M−0.9%419M−2.8%412M−5.1%Not reported

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionStable
CAGR

+0.4%

FY2020
381.0M
FY2025
389.0M

5 years selected · on the chart

01—History

Weighted Avg Shares (Diluted) History

Year-over-year comparison from 10-K annual reports

  7. 389.0M
YoY changeLargest recent move+15.1%in FY20Latest +1.3%

02—Ledger

Weighted Avg Shares (Diluted), period by period

PeriodValueChangeSource
FY2025389.0M+1.3%10-K
FY2024384.0M+0.5%10-K
FY2023382.0M−8.2%10-K
FY2022416.0M−3.5%10-K
FY2021431.0M+13.1%10-K
FY2020381.0M+15.1%10-K
FY2019331.0M—10-K

03—Questions

What is weighted avg shares (diluted)?

Weighted average shares outstanding (diluted) includes the basic share count plus all potentially dilutive securities such as stock options, warrants, and convertible bonds. It is used as the denominator to calculate diluted earnings per share.

What is Moderna, Inc.'s current weighted avg shares (diluted)?

Moderna, Inc. (MRNA) annual weighted avg shares (diluted) for 2025 was 389.0M, a 1.30% increase from 2024. Moderna, Inc. weighted avg shares (diluted) for the quarter ending March 31, 2026 was 395.0M.

What was Moderna, Inc.'s weighted avg shares (diluted) in 2024?

Moderna, Inc. annual weighted avg shares (diluted) for 2024 was 384.0M, a 0.52% increase from 2023.

What was Moderna, Inc.'s weighted avg shares (diluted) in 2023?

Moderna, Inc. annual weighted avg shares (diluted) for 2023 was 382.0M, a 8.17% decline from 2022.

What is Moderna, Inc.'s 5-year weighted avg shares (diluted) CAGR?

Moderna, Inc. weighted avg shares (diluted) grew at a compound annual growth rate (CAGR) of 0.42% from FY2020 to FY2025, going from 381.0M to 389.0M over 5 years.

Company
Moderna, Inc.
Ticker
MRNA
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
View company profile →